Usana Health Sciences (USNA) Net Income towards Common Stockholders (2016 - 2026)
Usana Health Sciences has reported Net Income towards Common Stockholders over the past 17 years, most recently at $7.0 million for Q2 2026.
- Quarterly Net Income towards Common Stockholders fell 25.09% to $7.0 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Apr 2026, down 73.73% year-over-year, with the annual reading at $11.5 million for FY2026, 72.71% down from the prior year.
- Net Income towards Common Stockholders was $7.0 million for Q2 2026 at Usana Health Sciences, up from -$1.6 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $22.5 million in Q2 2022 and troughed at -$6.7 million in Q3 2025.
- The 5-year median for Net Income towards Common Stockholders is $12.1 million (2022), against an average of $11.9 million.
- Year-over-year, Net Income towards Common Stockholders skyrocketed 31.04% in 2023 and then plummeted 162.81% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $12.8 million in 2022, then surged by 31.04% to $16.8 million in 2023, then crashed by 73.26% to $4.5 million in 2024, then plummeted by 248.57% to -$6.7 million in 2025, then soared by 204.46% to $7.0 million in 2026.
- Per Business Quant, the three most recent readings for USNA's Net Income towards Common Stockholders are $7.0 million (Q2 2026), -$1.6 million (Q1 2026), and -$6.7 million (Q3 2025).